Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III placebo-controlled trial of Fufang Yinxingye Pian for mild-to-moderate vascular dementia
ChiCTR2300072313Phase 3Completed
- Sponsor
- China-Japan Friendship Hospital
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of fufang yinxingye in vascular dementia (2 arms), sponsored by China-Japan Friendship Hospital. Primary endpoint: Alzheimer’s Disease Assessment Scale-Cognitive Subscale. Started Nov 2020; status: completed.
02
Drugs
fufang yinxingye
03
Conditions
vascular dementia
Beyond the preview
Go deeper on ChiCTR2300072313.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300072313.